PortfoliosLab logoPortfoliosLab logo
DGX vs. VALE
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

DGX vs. VALE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Quest Diagnostics Incorporated (DGX) and Vale S.A. (VALE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, DGX achieves a 18.06% return, which is significantly lower than VALE's 20.57% return. Over the past 10 years, DGX has underperformed VALE with an annualized return of 12.33%, while VALE has yielded a comparatively higher 22.05% annualized return.


DGX

1D
-0.38%
1M
6.40%
YTD
18.06%
6M
12.22%
1Y
15.46%
3Y*
16.40%
5Y*
11.96%
10Y*
12.33%

VALE

1D
2.28%
1M
-6.71%
YTD
20.57%
6M
23.80%
1Y
73.31%
3Y*
12.85%
5Y*
2.38%
10Y*
22.05%
*Multi-year figures are annualized to reflect compound growth (CAGR)

DGX vs. VALE - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
DGX
Quest Diagnostics Incorporated
18.06%17.20%11.77%-10.05%-7.80%47.86%14.11%31.13%-13.84%9.16%
VALE
Vale S.A.
20.57%60.70%-38.83%1.57%32.54%-1.45%32.40%2.72%12.25%68.03%

Correlation

The correlation between DGX and VALE is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.09

Correlation (3Y)
Calculated over the trailing 3-year period

0.15

Correlation (5Y)
Calculated over the trailing 5-year period

0.14

Correlation (10Y)
Calculated over the trailing 10-year period

0.17

Correlation (All Time)
Calculated using the full available price history since Mar 21, 2002

0.22

The correlation between DGX and VALE shifts across timeframes, from 0.09 (1 year) to 0.22 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

DGX:

$22.74B

VALE:

$67.15B

EPS

DGX:

$9.10

VALE:

$0.65

PE Ratio

DGX:

22.31

VALE:

24.04

PS Ratio

DGX:

2.03

VALE:

1.70

PB Ratio

DGX:

3.09

VALE:

1.83

Total Revenue (TTM)

DGX:

$11.28B

VALE:

$39.53B

Gross Profit (TTM)

DGX:

$3.75B

VALE:

$13.65B

EBITDA (TTM)

DGX:

$1.98B

VALE:

$14.33B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

DGX vs. VALE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DGX
DGX Risk / Return Rank: 6464
Overall Rank
DGX Sharpe Ratio Rank: 6565
Sharpe Ratio Rank
DGX Sortino Ratio Rank: 6161
Sortino Ratio Rank
DGX Omega Ratio Rank: 5858
Omega Ratio Rank
DGX Calmar Ratio Rank: 6868
Calmar Ratio Rank
DGX Martin Ratio Rank: 6767
Martin Ratio Rank

VALE
VALE Risk / Return Rank: 8989
Overall Rank
VALE Sharpe Ratio Rank: 9292
Sharpe Ratio Rank
VALE Sortino Ratio Rank: 8888
Sortino Ratio Rank
VALE Omega Ratio Rank: 8888
Omega Ratio Rank
VALE Calmar Ratio Rank: 8888
Calmar Ratio Rank
VALE Martin Ratio Rank: 9191
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DGX vs. VALE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Quest Diagnostics Incorporated (DGX) and Vale S.A. (VALE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


DGXVALEDifference
Sharpe ratioReturn per unit of total volatility

-1.62

Sortino ratioReturn per unit of downside risk

-1.66

Omega ratioGain probability vs. loss probability

1.14

1.37

-0.23

Calmar ratioReturn relative to maximum drawdown

1.34

3.71

-2.37

Martin ratioReturn relative to average drawdown

2.79

12.21

-9.42

DGX vs. VALE - Sharpe Ratio Comparison

The current DGX Sharpe Ratio is 0.68, which is lower than the VALE Sharpe Ratio of 2.30. The chart below compares the historical Sharpe Ratios of DGX and VALE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

DGX vs. VALE - Drawdown Comparison

The maximum DGX drawdown since its inception was -49.46%, smaller than the maximum VALE drawdown of -92.78%. Use the drawdown chart below to compare losses from any high point for DGX and VALE.


Loading charts...

Drawdown Indicators


DGXVALEDifference

Max Drawdown

Largest peak-to-trough decline

-49.46%

-92.78%

+43.32%

Max Drawdown (1Y)

Largest decline over 1 year

-11.55%

-19.85%

+8.30%

Max Drawdown (3Y)

Largest decline over 3 years

-16.57%

-41.94%

+25.37%

Max Drawdown (5Y)

Largest decline over 5 years

-28.62%

-49.79%

+21.17%

Max Drawdown (10Y)

Largest decline over 10 years

-36.60%

-57.60%

+21.00%

Current Drawdown

Current decline from peak

-3.76%

-11.84%

+8.08%

Average Drawdown

Average peak-to-trough decline

-11.89%

-36.69%

+24.80%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.56%

6.02%

-0.46%

Volatility

DGX vs. VALE - Volatility Comparison

The current volatility for Quest Diagnostics Incorporated (DGX) is 6.09%, while Vale S.A. (VALE) has a volatility of 9.16%. This indicates that DGX experiences smaller price fluctuations and is considered to be less risky than VALE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


DGXVALEDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.09%

9.16%

-3.07%

Volatility (6M)

Calculated over the trailing 6-month period

16.94%

26.35%

-9.41%

Volatility (1Y)

Calculated over the trailing 1-year period

23.01%

32.06%

-9.05%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

21.81%

35.47%

-13.66%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

23.79%

40.84%

-17.05%

Dividends

DGX vs. VALE - Dividend Comparison

DGX's dividend yield for the trailing twelve months is around 1.61%, less than VALE's 3.66% yield.


PositionTTM20252024202320222021202020192018201720162015
DGX
Quest Diagnostics Incorporated
1.61%1.82%1.96%2.02%1.66%1.40%1.85%1.99%2.34%1.83%1.72%2.07%
VALE
Vale S.A.
3.66%7.29%11.41%7.75%8.63%19.70%2.72%2.63%4.16%3.77%1.06%7.48%

Financials

DGX vs. VALE - Financials Comparison

This section allows you to compare key financial metrics between Quest Diagnostics Incorporated and Vale S.A.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


5.00B10.00B15.00B20222023202420252026
2.90B
9.26B
(DGX) Total Revenue
(VALE) Total Revenue
Values in USD except per share items

DGX vs. VALE - Profitability Comparison

The chart below illustrates the profitability comparison between Quest Diagnostics Incorporated and Vale S.A. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%40.0%50.0%60.0%70.0%20222023202420252026
32.5%
33.0%
Portfolio components
DGX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Quest Diagnostics Incorporated reported a gross profit of 942.00M and revenue of 2.90B. Therefore, the gross margin over that period was 32.5%.

VALE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Vale S.A. reported a gross profit of 3.06B and revenue of 9.26B. Therefore, the gross margin over that period was 33.0%.

DGX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Quest Diagnostics Incorporated reported an operating income of 399.00M and revenue of 2.90B, resulting in an operating margin of 13.8%.

VALE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Vale S.A. reported an operating income of 2.67B and revenue of 9.26B, resulting in an operating margin of 28.8%.

DGX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Quest Diagnostics Incorporated reported a net income of 252.00M and revenue of 2.90B, resulting in a net margin of 8.7%.

VALE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Vale S.A. reported a net income of 1.89B and revenue of 9.26B, resulting in a net margin of 20.5%.


Frequently Asked Questions


DGX and VALE have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

VALE has higher volatility (9.16%) compared to DGX (6.09%). In terms of maximum drawdown, DGX dropped -49.46% vs VALE's -92.78%.

VALE currently has the higher Sharpe Ratio (2.30 vs 0.68), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for DGX and VALE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer